Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy

Completed · Not applicable

Conditions studied: Head and Neck Cancer, Radiation Dermatitis

In brief

This is a single site, randomized, open-label comparison pilot study to assess the feasibility and effectiveness of KeraStat Cream compared with routine skin care (RSC) in managing radiotherapy-induced early adverse skin reaction (EASR) in patients undergoing radiotherapy to the head and/or neck. Hypothesis: The use of KeraStat Cream in patients receiving radiotherapy for head and neck is feasible, tolerable, and reduces the severity of early adverse skin reaction in the treated region of interest.

Key facts

Study ID
NCT04173247
Run by
Wake Forest University Health Sciences
People needed
28
Starts
2020-07-27
Expected to finish
2022-10-07
Last updated by the study team
2025-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.